Pulmonary vascular distensibility with passive leg raise is comparable to exercise and predictive of clinical outcomes in pulmonary hypertension.
Autor: | Kozitza CJ; Department of Biomedical Engineering Madison Wisconsin USA., Dharmavaram N; Department of Medicine Cardiovascular Division Madison Wisconsin USA., Tao R; Department of Medicine University of Wisconsin-Madison Madison Wisconsin USA., Tabima DM; Department of Biomedical Engineering Madison Wisconsin USA., Chesler NC; Department of Biomedical Engineering, Edwards Lifesciences Foundation Cardiovascular Innovation and Research Center University of California, Irvine Irvine California USA., Raza F; Department of Medicine Cardiovascular Division Madison Wisconsin USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Pulmonary circulation [Pulm Circ] 2022 Jan 12; Vol. 12 (1), pp. e12029. Date of Electronic Publication: 2022 Jan 12 (Print Publication: 2022). |
DOI: | 10.1002/pul2.12029 |
Abstrakt: | Pulmonary vascular distensibility ( α ) is a marker of the ability of the pulmonary vasculature to dilate in response to increases in cardiac output, which protects the right ventricle from excessive increases in afterload. α measured with exercise predicts clinical outcomes in pulmonary hypertension (PH) and heart failure. In this study, we aim to determine if α measured with a passive leg raise (PLR) maneuver is comparable to α with exercise. Invasive cardiopulmonary exercise testing (iCPET) was performed with hemodynamics recorded at three stages: rest, PLR and peak exercise. Four hemodynamic phenotypes were identified (2019 ECS guidelines): pulmonary arterial hypertension (PAH) ( n = 10), isolated post-capillary (Ipc-PH) ( n = 18), combined pre-/post-capillary PH (Cpc-PH) ( n = 15), and Control (no significant PH at rest and exercise) ( n = 7). Measurements of mean pulmonary artery pressure, pulmonary artery wedge pressure, and cardiac output at each stage were used to calculate α. There was no statistical difference between α-exercise and α-PLR (0.87 ± 0.68 and 0.78 ± 0.47% per mmHg, respectively). The peak exercise- and PLR-based calculations of α among the four hemodynamic groups were: Ipc-PH = Ex: 0.94 ± 0.30, PLR: 1.00 ± 0.27% per mmHg; Cpc-PH = Ex: 0.51 ± 0.15, PLR: 0.47 ± 0.18% per mmHg; PAH = Ex: 0.39 ± 0.23, PLR: 0.34 ± 0.18% per mmHg; and the Control group: Ex: 2.13 ± 0.91, PLR: 1.45 ± 0.49% per mmHg. Patients with α ≥ 0.7% per mmHg had reduced cardiovascular death and hospital admissions at 12-month follow-up. In conclusion, α-PLR is feasible and may be equally predictive of clinical outcomes as α-exercise in patients who are unable to exercise or in programs lacking iCPET facilities. Competing Interests: The authors declare that there are no conflict of interests. (© 2021 The Authors. Pulmonary Circulation published by John Wiley & Sons Ltd on behalf of Pulmonary Vascular Research Institute.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |